{"id":"W2952131264","doi":"10.1097/01.hs9.0000558648.00957.de","title":"S107 FIVE‐YEAR FOLLOW‐UP OF PATIENTS RECEIVING IBRUTINIB FOR FIRST‐LINE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Ibrutinib; Medicine; Chronic lymphocytic leukemia; Chlorambucil; Internal medicine; Hazard ratio; Adverse effect; Neutropenia; Progression-free survival; Bendamustine; Clinical endpoint; Oncology; Leukemia; Randomized controlled trial; Confidence interval; Toxicity; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009403268,0.000287795,0.0008360867,0.0006649706,0.000518467,0.0006376824,0.0003498654,0.0008163035,0.004158534],"category_scores_gemma":[0.001435582,0.0001781693,0.001129923,0.0005778956,0.0001877111,0.0006039275,0.0003461232,0.0008568317,0.0008710303],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007350557,"about_ca_system_score_gemma":0.0004153087,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002385797,"about_ca_topic_score_gemma":0.002249394,"domain_scores_codex":[0.9995726,0.00008685437,0.00005918888,0.00009757861,0.00007978457,0.0001039668],"domain_scores_gemma":[0.9984844,0.0003180526,0.0005656707,0.00007999042,0.000210683,0.0003412351],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02716886,0.001009943,0.9438352,0.0001255218,0.0004830985,0.0006072314,0.0001689143,0.0004973294,0.001893264,0.0000457816,0.002086119,0.02207869],"study_design_scores_gemma":[0.001226583,0.009987118,0.9848298,0.00003300125,0.0005264753,0.0006472902,0.00009690085,0.0005706057,0.0004129784,0.00004569011,0.001601193,0.00002238913],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9950578,0.0009117488,0.0001198532,0.0001009142,0.00002366221,0.00008254323,0.00228651,0.00001485512,0.001402167],"genre_scores_gemma":[0.9953868,0.0001709298,0.00007171668,0.0001259132,0.00002597458,0.00008169754,0.003393496,0.000002869885,0.0007406431],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004158534,"threshold_uncertainty_score":0.01391166,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02183908616843046,"score_gpt":0.287915697708241,"score_spread":0.2660766115398106,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}